Legis Daily

A bill to amend title XVIII of the Social Security Act to impose certain requirements under the Medicare program with respect to outlier prescribers of opioids.

USA115th CongressS-2920| Senate 
| Updated: 5/22/2018
Claire McCaskill

Claire McCaskill

Democratic Senator

Missouri

Cosponsors (2)
Joe Manchin (Independent)Patrick Toomey (Republican)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act of 2018 This bill requires the Centers for Medicare & Medicaid Services (CMS) to identify outlier prescribers of opioids under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans. Specifically, the CMS must: (1) establish an opioid-prescription threshold for determining whether a prescriber is an outlier compared to other prescribers, based on specialty and geographic area; (2) use National Provider Identifiers (unique provider identification numbers currently included on claims for covered drugs) to identify outlier prescribers; and (3) annually notify identified outlier prescribers of their status and provide them with resources on proper prescribing methods. The CMS may also identify and notify outlier prescribers based on co-prescriptions of covered drugs that have adverse effects when used in combination with opioids. Persistent outlier prescribers are subject to additional requirements.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 22, 2018
Introduced in Senate
May 22, 2018
Read twice and referred to the Committee on Finance.
  • May 22, 2018
    Introduced in Senate


  • May 22, 2018
    Read twice and referred to the Committee on Finance.

Health

Related Bills

  • S 115-3120: HEAL Act of 2018
  • HR 115-5716: COMPASS Act
Drug, alcohol, tobacco useDrug trafficking and controlled substancesHealth care costs and insuranceHealth information and medical recordsMedicarePrescription drugs

A bill to amend title XVIII of the Social Security Act to impose certain requirements under the Medicare program with respect to outlier prescribers of opioids.

USA115th CongressS-2920| Senate 
| Updated: 5/22/2018
Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act of 2018 This bill requires the Centers for Medicare & Medicaid Services (CMS) to identify outlier prescribers of opioids under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans. Specifically, the CMS must: (1) establish an opioid-prescription threshold for determining whether a prescriber is an outlier compared to other prescribers, based on specialty and geographic area; (2) use National Provider Identifiers (unique provider identification numbers currently included on claims for covered drugs) to identify outlier prescribers; and (3) annually notify identified outlier prescribers of their status and provide them with resources on proper prescribing methods. The CMS may also identify and notify outlier prescribers based on co-prescriptions of covered drugs that have adverse effects when used in combination with opioids. Persistent outlier prescribers are subject to additional requirements.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 22, 2018
Introduced in Senate
May 22, 2018
Read twice and referred to the Committee on Finance.
  • May 22, 2018
    Introduced in Senate


  • May 22, 2018
    Read twice and referred to the Committee on Finance.
Claire McCaskill

Claire McCaskill

Democratic Senator

Missouri

Cosponsors (2)
Joe Manchin (Independent)Patrick Toomey (Republican)

Finance Committee

Health

Related Bills

  • S 115-3120: HEAL Act of 2018
  • HR 115-5716: COMPASS Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug, alcohol, tobacco useDrug trafficking and controlled substancesHealth care costs and insuranceHealth information and medical recordsMedicarePrescription drugs